EUCTR2015-000736-15-GR进行中（未招募）1 期
Additive Effect of Twice Daily Brinzolamide 1% /Brimonidine 0.2% Fixed Dose Combination as an Adjunctive Therapy to a Prostaglandin Analogue - Simbrinza BID as an Adjunctive to Prostaglandin Analogue (PGA)
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Diagnosed with either open-angle glaucoma or ocular hypertension.
- •2. Must sign an informed consent form.
- •3. Willing and able to attend all study visits.
- •4. Other protcol-specified inclusion criteria may apply
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 140
排除标准
- •1. Women of childbearing potential who are pregnant, breastfeeding, intend to become pregnant during the study, or not using adequate birth
- •control methods to prevent pregnancy throughout the study
- •2. Any form of glaucoma other than open-angle glucoma or ocular hypertension
- •3. Ocular disease, trauma, infection, inflammation, pathology, or surgery as specified in the protocol
- •4. Any other conditions including severe illness which would make the subject, in the opinion of the Investigator, unsuitable for the study
- •5. Other protocol-specified exlcusion criteria may apply
研究者
相似试验
进行中（未招募）
1 期
A study to investigate the combined effect of Simbrinza with other eye medication on GlaucomaEUCTR2015-000736-15-ESAlcon Research, Ltd.280
进行中（未招募）
1 期
A study to investigate the combined effect of Simbrinza with other eye medication on GlaucomaOcular Hypertension Open-angle GlaucomaMedDRA version: 20.0Level: PTClassification code 10030043Term: Ocular hypertensionSystem Organ Class: 10015919 - Eye disordersMedDRA version: 20.0Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersEUCTR2015-000736-15-DEAlcon Research, Ltd.280
进行中（未招募）
1 期
A study to investigate the combined effect of Simbrinza with other eye medication on GlaucomaOcular Hypertension Open-angle GlaucomaMedDRA version: 20.0 Level: PT Classification code 10030043 Term: Ocular hypertension System Organ Class: 10015919 - Eye disordersMedDRA version: 20.0 Level: PT Classification code 10030348 Term: Open angle glaucoma System Organ Class: 10015919 - Eye disordersEUCTR2015-000736-15-GBAlcon Research, Ltd.188
进行中（未招募）
1 期
A study to investigate the combined effect of Simbrinza with other eye medication on GlaucomaOcular Hypertension Open-angle GlaucomaMedDRA version: 18.0Level: PTClassification code 10030043Term: Ocular hypertensionSystem Organ Class: 10015919 - Eye disordersMedDRA version: 18.0Level: PTClassification code 10030348Term: Open angle glaucomaSystem Organ Class: 10015919 - Eye disordersEUCTR2015-000736-15-FRAlcon Research, Ltd.188
进行中（未招募）
1 期
A study to investigate the combined effect of Simbrinza with another eye medication on GlaucomaEUCTR2016-000176-20-NLAlcon Research Ltd134